中国のERCP(内視鏡的逆行性胆管膵管造影)処置動向(~2020)

調査会社GlobalData社が発行したリサーチレポート(データ管理コード:GDMECC0395PDB)
◆英語タイトル:China Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020
◆発行会社/調査会社:GlobalData
◆商品コード:GDMECC0395PDB
◆発行日:2014年7月14日
◆調査対象地域:中国
◆産業分野:医療機器・装備
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥19,775見積依頼/購入/質問フォーム
Site License Price(同一国内共有可)USD350 ⇒換算¥39,550見積依頼/購入/質問フォーム
Enterprisewide Price(複数国内共有可)USD525 ⇒換算¥59,325見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[中国のERCP(内視鏡的逆行性胆管膵管造影)処置動向(~2020)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

China Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020

Summary

GlobalData’s new report, “China Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020″, provides key market data on the China Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures. The report provides procedure volumes within market segments – Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures (ERCP Plastic Biliary Stenting Procedures and ERCP Metal Biliary Stenting Procedures (ERCP Metal – Non-Covered Biliary Stenting Procedures, ERCP Metal – Partially Covered Biliary Stenting Procedures and ERCP Metal – Fully Covered Biliary Stenting Procedures)) and Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures without Stenting.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.

Scope

- Procedure volumes by segment – Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures (ERCP Plastic Biliary Stenting Procedures and ERCP Metal Biliary Stenting Procedures (ERCP Metal – Non-Covered Biliary Stenting Procedures, ERCP Metal – Partially Covered Biliary Stenting Procedures and ERCP Metal – Fully Covered Biliary Stenting Procedures)) and Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures without Stenting.
- Projections for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.

Reasons to buy

- Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Develop market-entry and market expansion strategies.

*** レポート目次(コンテンツ)***

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Introduction 4
2.1 What Is This Report About? 4
2.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Segmentation 4
2.3 Definitions of Procedures Covered in the Report 4
3 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, China 6
3.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, China, 2005-2013 6
3.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, China, 2013-2020 8
3.3 Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, China, 2005-2013 10
3.4 Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, China, 2013-2020 12
3.5 ERCP Metal Biliary Stenting Procedures, China, 2005-2013 14
3.6 ERCP Metal Biliary Stenting Procedures, China, 2013-2020 16
4 Appendix 18
4.1 Research Methodology 19
4.1.1 Coverage 19
4.1.2 Secondary Research 19
4.1.3 Primary Research 20
4.1.4 Market Modeling and Forecasting 21
4.1.5 Company Share Analysis 24
4.1.6 Distribution Share Analysis 25
4.2 Expert Panel 25
4.3 GlobalData Consulting 26
4.4 Contact Us 26
4.5 Disclaimer 26

1.1 List of Tables
Table 1: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, China, Historic, 2005-2013 7
Table 2: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, China, Forecast, 2013-2020 9
Table 3: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, China, Historic, 2005-2013 11
Table 4: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, China, Forecast, 2013-2020 13
Table 5: ERCP Metal Biliary Stenting Procedures, China, Historic, 2005-2013 15
Table 6: ERCP Metal Biliary Stenting Procedures, China, Forecast, 2013-2020 17
Table 7: Total Number of Primary Research Participants, General Surgery Market, by Country 21

1.2 List of Figures
Figure 1: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, China, Historic, 2005-2013 6
Figure 2: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, China, Forecast, 2013-2020 8
Figure 3: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, China, Historic, 2005-2013 10
Figure 4: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, China, Forecast, 2013-2020 12
Figure 5: ERCP Metal Biliary Stenting Procedures, China, Historic, 2005-2013 14
Figure 6: ERCP Metal Biliary Stenting Procedures, China, Forecast, 2013-2020 16
Figure 7: GlobalData Epidemiology-Based Forecasting Model 23
Figure 8: GlobalData Capital Equipment-Based Forecasting Model 24
Figure 9: Primary Interviews by Participant Type (%) 25

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GDMECC0395PDB )"中国のERCP(内視鏡的逆行性胆管膵管造影)処置動向(~2020)" (英文:China Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020)はGlobalData社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。